...
机译:连续MMF早期将环孢菌素转化为西罗莫司的疗效和安全性–概念研究后的四年结果
Department of Nephrology Clinical Immunology University Hospital François Rabelais University Tours France;
Department of Nephrology and Transplantation University Hospital Poitiers France;
Department of Nephrology and Transplantation Necker Hospital Paris France;
Department of Nephrology and Transplantation University Hospital Rouen France;
Department of Nephrology and Transplantation University Hospital Amiens France;
Department of Nephrology and Transplantation University Hospital Caen France;
Department of Nephrology and Transplantation University Hospital Strasbourg France;
Department of Nephrology and Transplantation University Hospital Limoges France;
Department of Nephrology and Transplantation University Hospital Rennes France;
Roche SAS Neuilly-sur-Seine France;
Department of Nephrology and Transplantation University Hospital Reims France;
Chronic allograft nephropathy; CsA; MMF; nephrotoxicity; renal function; renal transplantation; SRL conversion;
机译:早期环孢菌素转化为西罗莫司的疗效和安全性以及Postconcept研究的连续4年MMF结果。
机译:早期环孢菌素转化对西罗莫司的疗效和安全性,持续的MMF-STESCOPT研究结果。
机译:早期环孢菌素转化对西罗莫司的疗效和安全性,持续的MMF-STESCOPT研究结果。
机译:Imani-1 TC3WP单药搭载概念研究试验试验研究Kaletra(LPV / R)作为艾滋病毒+ ARV天真患者单药HAART的安全性和有效性 - 临时分析受试者完成最终的48周数据
机译:免疫抑制剂mTOR抑制剂依维莫司和西罗莫司与钙调神经磷酸酶抑制剂环孢霉素和他克莫司联用的体内和体外比较肾毒性研究
机译:西罗莫司和紫杉醇洗脱支架在急性心肌梗死患者中的长期安全性和有效性:四年观察性研究
机译:早期环孢菌素转化为西罗莫司的疗效和安全性以及Postconcept研究的连续4年MMF结果。